Literature DB >> 16304327

Transesophageal echocardiographic evaluation of diastolic function.

Leanne Groban1, Sylvia Y Dolinski.   

Abstract

Diastolic dysfunction is increasingly recognized as a cause of hemodynamic instability in the perioperative setting. Difficulty weaning from cardiopulmonary bypass and an increased need for inotropic support can occur in the absence of systolic impairment. Diastolic dysfunction can also impede hemodynamic stabilization and weaning progress in the mechanically ventilated critically ill patient. The use of transesophageal echocardiography in the ICU can assist in diagnosing the presence and progression of diastolic impairment, which may help to target therapeutic interventions that lead to positive outcomes. This review summarizes the conventional and new echocardiographic modalities for evaluating diastolic function in the perioperative setting.

Entities:  

Mesh:

Year:  2005        PMID: 16304327     DOI: 10.1378/chest.128.5.3652

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.

Authors:  Joseph R Goldenberg; Andrew N Carley; Ruiping Ji; Xiaokan Zhang; Matt Fasano; P Christian Schulze; E Douglas Lewandowski
Journal:  Circulation       Date:  2019-03-26       Impact factor: 29.690

2.  Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia.

Authors:  R Maharaj
Journal:  J Saudi Heart Assoc       Date:  2012-02-01

Review 3.  Diastolic dysfunction, cardiovascular aging, and the anesthesiologist.

Authors:  David Sanders; Michael Dudley; Leanne Groban
Journal:  Anesthesiol Clin       Date:  2009-09

4.  Influence of intraaortic balloon pump counterpulsation on transesophageal echocardiography derived determinants of diastolic function.

Authors:  Martina Nowak-Machen; Jan N Hilberath; Peter Rosenberger; Eckhard Schmid; Stavros G Memtsoudis; Johannes Angermair; Jayshree K Tuli; Stanton K Shernan
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.